During the onset of benign paroxysmal positional vertigo (BPPV), patients with motion sickness may experience more severe vestibular symptoms, which may affect the occurrence of residual dizziness (RD). OBJECTIVES: To study the correlation between RD after BPPV and motion sickness.
If the study finds a significant link, audiologists and vestibular clinicians should consider screening for motion sickness history before BPPV repositioning to better counsel patients on residual dizziness risk — but results must be reviewed before changing practice.
Identifying pre-existing motion sickness susceptibility as a predictor of residual dizziness after BPPV repositioning could help clinicians set more accurate patient expectations and guide post-treatment management.
- 01Study investigates residual dizziness after BPPV (inner-ear crystal repositioning) treatment and its link to motion sickness history.
- 02BPPV is one of the most common causes of vertigo (spinning dizziness) treated in audiology and ENT settings.
- 03Residual dizziness after successful repositioning maneuvers is a frequently reported but poorly understood complaint.
- 04Observational design limits causal conclusions.
- 05Published in Acta Oto-Laryngologica (inferred from DOI prefix) as a peer-reviewed study.
There is a correlation between residual dizziness after BPPV repositioning and pre-existing motion sickness susceptibility.
studypartially supported- PMID
- 42077109
- DOI
- 10.1080/00016489.2026.2656280.
- Journal
- Acta Oto-Laryngologica
- Publication type
- research_article
- Evidence level
- 3
- Population
- Patients with BPPV who underwent repositioning maneuvers
- Intervention
- Canalith repositioning maneuver for BPPV
Primary outcomes
Residual dizziness following BPPV repositioning; Correlation with pre-existing motion sickness susceptibility